Editorial
doi: 10.1016/j.jcin.2021.11.022.
Acetylcholine (Re)challenge: From Diagnosis to Targeted Therapy
Affiliations
- PMID: 34991827
- DOI: 10.1016/j.jcin.2021.11.022
Item in Clipboard
Editorial
Acetylcholine (Re)challenge: From Diagnosis to Targeted Therapy
JACC Cardiovasc Interv.
.
Free article
No abstract available
Keywords: INOCA; acetylcholine; angina; coronary spasm.
Conflict of interest statement
Funding Support and Author Disclosures Dr Ford is a consultant and speaker for and has received honoraria from Abbott Vascular, Boston Scientific, Boehringer Ingelheim, Biotronik, Bio-Excel, and Novartis. Dr Mikhail has reported that he has no relationships relevant to the contents of this paper to disclose.
Comment on
-
Acetylcholine Rechallenge: A First Step Toward Tailored Treatment in Patients With Coronary Artery Spasm.JACC Cardiovasc Interv. 2022 Jan 10;15(1):65-75. doi: 10.1016/j.jcin.2021.10.003. JACC Cardiovasc Interv. 2022. PMID: 34991826
